Amgen Historical Income Statement

AMGN Stock  USD 286.30  4.53  1.61%   
Historical analysis of Amgen income statement accounts such as Interest Expense of 3 B, Selling General Administrative of 5.8 B or Total Revenue of 29.6 B can show how well Amgen Inc performed in making a profits. Evaluating Amgen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Amgen's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Amgen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amgen Inc is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Amgen Income Statement Analysis

Amgen Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Amgen shareholders. The income statement also shows Amgen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Amgen Income Statement Chart

Amgen Inc Income Statement is one of the three primary financial statements used for reporting Amgen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amgen Inc revenue and expense. Amgen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Amgen's Cost Of Revenue is very stable compared to the past year. As of the 28th of March 2024, Total Operating Expenses is likely to grow to about 12.4 B, while Operating Income is likely to drop about 4.1 B.

Total Revenue

Total revenue comprises all receipts Amgen Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Amgen Inc minus its cost of goods sold. It is profit before Amgen operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Amgen Inc. It is also known as Amgen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Amgen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
At this time, Amgen's Cost Of Revenue is very stable compared to the past year. As of the 28th of March 2024, Total Operating Expenses is likely to grow to about 12.4 B, while Operating Income is likely to drop about 4.1 B.
 2021 2022 2023 2024 (projected)
Interest Expense1.2B1.4B2.9B3.0B
Depreciation And Amortization3.4B3.4B4.1B4.3B

Amgen income statement Correlations

0.770.520.80.680.830.160.180.360.930.680.350.560.530.060.540.43-0.66-0.03-0.61-0.770.830.56-0.12-0.57
0.770.660.790.680.860.280.350.270.90.760.310.10.540.10.430.39-0.630.04-0.39-0.850.590.83-0.61-0.84
0.520.660.870.90.850.640.660.660.660.950.64-0.060.690.180.790.27-0.120.09-0.08-0.310.230.29-0.19-0.31
0.80.790.870.980.960.590.640.730.890.940.70.280.770.210.810.46-0.350.07-0.26-0.530.580.4-0.12-0.41
0.680.680.90.980.90.70.740.830.790.930.790.20.790.270.850.43-0.190.12-0.1-0.360.440.25-0.04-0.27
0.830.860.850.960.90.390.470.530.950.960.50.280.70.070.770.4-0.52-0.04-0.45-0.690.660.55-0.24-0.56
0.160.280.640.590.70.390.970.910.240.490.94-0.260.580.50.630.350.390.370.530.17-0.15-0.01-0.030.17
0.180.350.660.640.740.470.970.910.310.560.94-0.190.590.490.650.350.310.340.460.08-0.030.07-0.040.11
0.360.270.660.730.830.530.910.910.390.60.980.110.650.460.760.390.260.30.310.10.14-0.110.250.22
0.930.90.660.890.790.950.240.310.390.830.380.420.620.040.620.44-0.67-0.06-0.57-0.830.810.66-0.28-0.67
0.680.760.950.940.930.960.490.560.60.830.560.140.720.090.830.33-0.35-0.02-0.31-0.510.490.41-0.19-0.43
0.350.310.640.70.790.50.940.940.980.380.560.080.640.480.730.420.240.320.340.080.11-0.020.180.2
0.560.1-0.060.280.20.28-0.26-0.190.110.420.140.080.16-0.090.20.21-0.5-0.16-0.59-0.330.790.00.560.0
0.530.540.690.770.790.70.580.590.650.620.720.640.16-0.250.680.86-0.18-0.4-0.23-0.320.360.20.0-0.21
0.060.10.180.210.270.070.50.490.460.040.090.48-0.09-0.250.08-0.450.330.980.610.2-0.14-0.05-0.020.07
0.540.430.790.810.850.770.630.650.760.620.830.730.20.680.080.36-0.1-0.06-0.17-0.20.40.150.120.06
0.430.390.270.460.430.40.350.350.390.440.330.420.210.86-0.450.36-0.25-0.58-0.29-0.350.360.26-0.02-0.18
-0.66-0.63-0.12-0.35-0.19-0.520.390.310.26-0.67-0.350.24-0.5-0.180.33-0.1-0.250.340.810.9-0.76-0.690.380.67
-0.030.040.090.070.12-0.040.370.340.3-0.06-0.020.32-0.16-0.40.98-0.06-0.580.340.630.23-0.23-0.06-0.080.04
-0.61-0.39-0.08-0.26-0.1-0.450.530.460.31-0.57-0.310.34-0.59-0.230.61-0.17-0.290.810.630.74-0.78-0.460.040.46
-0.77-0.85-0.31-0.53-0.36-0.690.170.080.1-0.83-0.510.08-0.33-0.320.2-0.2-0.350.90.230.74-0.78-0.880.550.85
0.830.590.230.580.440.66-0.15-0.030.140.810.490.110.790.36-0.140.40.36-0.76-0.23-0.78-0.780.530.05-0.45
0.560.830.290.40.250.55-0.010.07-0.110.660.41-0.020.00.2-0.050.150.26-0.69-0.06-0.46-0.880.53-0.74-0.8
-0.12-0.61-0.19-0.12-0.04-0.24-0.03-0.040.25-0.28-0.190.180.560.0-0.020.12-0.020.38-0.080.040.550.05-0.740.72
-0.57-0.84-0.31-0.41-0.27-0.560.170.110.22-0.67-0.430.20.0-0.210.070.06-0.180.670.040.460.85-0.45-0.80.72
Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization753M3.6B3.4B3.4B4.1B4.3B
Interest Expense1.3B1.3B1.2B1.4B2.9B3.0B
Selling General Administrative4.4B4.8B4.5B4.6B5.5B5.8B
Total Revenue23.4B25.4B26.0B26.3B28.2B29.6B
Gross Profit19.0B19.3B19.5B19.9B19.7B20.7B
Other Operating Expenses13.7B16.3B16.8B16.8B20.3B21.3B
Operating Income9.7B5.8B6.0B5.3B7.9B4.1B
Ebit9.7B5.8B6.0B5.3B7.9B4.3B
Ebitda10.4B9.4B9.4B8.8B7.9B5.2B
Cost Of Revenue4.4B6.2B6.5B6.4B8.5B8.9B
Total Operating Expenses9.3B10.1B10.4B10.4B11.8B12.4B
Income Before Tax9.1B8.1B6.7B7.3B7.9B4.0B
Total Other Income Expense Net(536M)2.3B696M2.0B(42M)(44.1M)
Net Income7.8B7.3B5.9B6.6B6.7B7.1B
Income Tax Expense1.3B869M808M794M1.1B830.4M
Research Development4.1B4.2B4.8B4.4B4.8B2.9B
Net Income Applicable To Common Shares7.8B7.3B5.9B6.6B7.5B5.0B
Net Income From Continuing Ops7.8B7.3B5.9B6.6B7.6B6.4B
Non Operating Income Net Other753M256M259M(814M)(732.6M)(696.0M)
Tax Provision1.3B869M808M794M1.2B1.4B
Interest Income928M674M753M256M230.4M218.9M
Net Interest Income(536M)(1.0B)(1.2B)(1.4B)(2.5B)(2.3B)
Reconciled Depreciation2.2B3.6B3.4B3.4B3.6B3.2B

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Moving against Amgen Stock

  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.73TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
  0.65DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.6VANI Vivani Medical Report 29th of March 2024 PairCorr
  0.56MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.